Douglas Lane & Associates’s GE HealthCare GEHC Stock Holding History

Douglas Lane & Associates’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.1M	Sell	360,475 -10,342	-3%	-$680K	0.31%	97
2026 Q1	$26.4M	Sell	370,817 -23,157	-6%	-$1.83M	0.38%	90
2025 Q4	$32.3M	Sell	393,974 -46,707	-11%	-$3.64M	0.44%	87
2025 Q3	$33.1M	Sell	440,681 -6,427	-1%	-$479K	0.46%	85
2025 Q2	$33.1M	Sell	447,108 -26,115	-6%	-$1.82M	0.48%	83
2025 Q1	$38.2M	Sell	473,223 -7,196	-1%	-$618K	0.56%	72
2024 Q4	$37.6M	Buy	480,419 +20,415	+4%	+$1.74M	0.53%	80
2024 Q3	$43.2M	Buy	460,004 +10,099	+2%	+$848K	0.59%	71
2024 Q2	$35.1M	Buy	449,905 +9,492	+2%	+$774K	0.5%	81
2024 Q1	$40M	Buy	440,413 +4,160	+1%	+$346K	0.57%	70
2023 Q4	$33.7M	Buy	436,253 +79,073	+22%	+$5.54M	0.52%	75
2023 Q3	$24.3M	Sell	357,180 -27,053	-7%	-$1.97M	0.41%	86
2023 Q2	$31.2M	Buy	384,233 +9,650	+3%	+$770K	0.5%	73
2023 Q1	$30.7M	Buy	+374,583	New	+$26.7M	0.51%	71

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Douglas Lane & Associates's GEHC Position: Q2 2026 in Review

Douglas Lane & Associates reduced its GE HealthCare (GEHC) stake by 2.8% in Q2 2026, selling an estimated $680K and leaving 360,475 shares worth $23.1M. The position accounts for 0.31% of the portfolio, ranked #97.

Douglas Lane & Associates first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $43.2M in Q3 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Douglas Lane & Associates held 360,475 shares of GE HealthCare worth $23.1M as of Q2 2026.
Douglas Lane & Associates sold 10,342 GE HealthCare shares in Q2 2026, an estimated $680K.
GE HealthCare made up 0.31% of Douglas Lane & Associates's portfolio in Q2 2026, its #97 holding.
Douglas Lane & Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
Douglas Lane & Associates's GE HealthCare position peaked at $43.2M in Q3 2024.
1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.